ðïž ç¬ç« è «çãã¥ãŒã¹ â 2026.11.15
ç¬ç«ã®è «çã»ããé¢é£ãã¥ãŒã¹ïŒè«æ èš7ä»¶
ðïž è «çã»ããé¢é£ãã¥ãŒã¹ â 2026.11.15
æ¬æ¥ 7ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ç¬çšã®å ç«ãã§ãã¯ãã€ã³ãé»å®³è¬ãã®ã«ããããããã¡ã©ããŒããšè¥æºçްèè «ã®èšåºç ç©¶ãJVIMãšJAVMAã«æ²èŒââèšåºçæçšç66.7%ãè¥æºçްèè «ã®å¥å¹ç46%ãéãå¯äœçšã¯5.9%(ã¡ã«ã¯ã»ã¢ããã«ãã«ã¹)
ð 2026.10.10
ç±³ã¡ã«ã¯ã»ã¢ããã«ãã«ã¹ã¯ãç¬çšã«äœãããæPD-1ã¢ãã¯ããŒãã«æäœãã®ã«ãããã(gilvetmab)ãã«ã€ããŠãèªç¶ã«çºçããããã®ç¬ã察象ãšããèšåºç ç©¶ãJournal of Veterinary Internal Medicine(JVIM)èªã«ãå ç«ãã§ãã¯ãã€ã³ãé»å®³è¬ã®äœçœ®ã¥ããè«ããè«æãJAVMAèªã«æ²èŒããããšçºè¡šããŸãããPD-1ã¯ãã现èãå ç«ã®æ»æãéããããã«å©çšããããã¬ãŒããã®äžã€ã§ãã®ã«ããããã¯ãããå€ããŠç¬èªèº«ã®å ç«ããããæ»æããããããè¬ã§ããJVIMã®ç ç©¶ã§ã¯å£è å æªæ§ã¡ã©ããŒããšç®èã»ç®äžã®è¥æºçްèè «ã®ç¬ãè©äŸ¡ããå®å šå¥å¹ã»éšåå¥å¹ã»ç å¢å®å®ãåãããèšåºçæçšçã¯å šäœã§66.7%ã§ãããã¹ããŒãžIIãIIIã®å£è å æªæ§ã¡ã©ããŒãã§ã¯å¥å¹ç20%ã§ã40%ã®ç¬ãç å¢å®å®ãä¿ã¡ãŸãããã¹ããŒãžIãIIIã®è¥æºçްèè «ã§ã¯å¥å¹ç46%ã§ãè©äŸ¡æéäžã«ç æ°ãé²è¡ãããŸã§ã®æéã®äžå€®å€ã«ã¯éããŸããã§ããã96%ã®ç¬ã§é«ãçæŽ»ã®è³ªãä¿ãããéãæå®³äºè±¡ã¯5.9%ã§ãæšæºçãªåŠçœ®ã§å¯Ÿå¿å¯èœã ã£ããšãããŠããŸããæäžã¯æãã¹ã¿ãã³è¬ãžãã§ã³ããã©ãã³ã®åæäžã®ããã30åãããŠç¹æ»ŽããŸãã
人ã®ããå»çã§åºã䜿ãããå ç«ãã§ãã¯ãã€ã³ãé»å®³è¬ããç¬ã§ãèšåºããŒã¿ãšãšãã«äœ¿ããæ®µéã«è¿ã¥ããŠããããšãç€ºãææã§ãããã ããã®ã«ããããã¯ç±³åœèŸ²åç(USDA)ã®ãæ¡ä»¶ä»ããæ¿èªã§ãå®å šæ§ã»æå¹æ§ã»å¹åã¯ãŸã å®å šã«ã¯è©äŸ¡ãããŠããããçŸæç¹ã§ã¯ç±³åœã§ã®ã¿äœ¿çšã§ããŸãããŸããçºè¡šè³æã§ã¯å¯Ÿè±¡é æ°ãå¯Ÿç §çŸ€ã®æç¡ãªã©ã®è©³çްã¯ç€ºãããŠããããæ°åã¯äŒæ¥ã®çºè¡šã«åºã¥ããã®ã§ããå£ã®äžã®é»ã£ãœãã§ããã®ãåºè¡ãå£èã®æªåãç®èã®ãããã«æ°ã¥ãããæ©ãã«å蚺ããæè¡ãæŸå°ç·æ²»çãå«ããæ²»çã®éžæè¢ãç£å»åž«ãšçžè«ããŸãããã
ð¥ å»çã»çŸç ã»äºé²
2. ð¥ å»çã»çŸç ã»äºé²
ç¬ã®éªšç€ã«ã§ãã骚èè «74äŸãåœé倿œèšã§è§£æãå šçåæéã®äžå€®å€ã¯79æ¥ââäœããã®æ²»çãåããç¬ã¯145æ¥ãæ²»çãªãã¯8æ¥ã蚺ææã®çŽ31%ã§è»¢ç§»(ãã¥ãŒãªãã倧åŠã»ããVet Comp Oncol)
ð 2026.08.22
骚èè «ã¯ç¬ã§æãå€ãåçºæ§ã®éªšã®ããã§ãå€ãã¯è¶³ã®éªšã«çºçããŸããã骚ç€ã«ã§ããããšã¯ãŸãã§ããŸãšãŸã£ãããŒã¿ãã»ãšãã©ãããŸããã§ãããã¹ã€ã¹ã®ãã¥ãŒãªãã倧åŠã®Csilla Fejösæ°ãCarla Rohrer Bleyæ°ããäžå¿ã«ãç±³ã³ãã©ãå·ç«å€§åŠãã«ããã®ã²ã«ã倧åŠãç±³ã«ãªãã©ã«ãã¢å€§åŠããŒãã¹æ ¡ãè±çç«ç£å»å€§åŠãäŒãããŒãã£å€§åŠãªã©æ¬§ç±³ã®å€æ°ã®æœèšãåå ããç ç©¶ããŒã ã¯ã2007ã2025幎ã«éªšç€ã®éªšèè «ãšèšºæãããç¬74é ãåŸãåãã«è§£æããVeterinary and Comparative Oncologyèªã«8æ22æ¥ã«ãªã³ã©ã€ã³çºè¡šããŸãããæãå€ãçç¶ã¯è¶³ãåŒãããè·è¡ã§84%ã«ã¿ããã骚ç€ã®äžã§ã¯è žéªšã«ã§ãããã®ã57%ãšæå€ã§ããã蚺ææã«ã¯ããã31%ã§ãã§ã«è»¢ç§»ããããå€ãã¯èºãžã®è»¢ç§»ã§ãããå šäœã®ç¡å¢æªçåæéã®äžå€®å€ã¯75æ¥ãå šçåæéã®äžå€®å€ã¯79æ¥ã§ãããäœããã®æ²»çãåããç¬ã§ã¯ç¡å¢æªçåæéã116æ¥(æ²»çãªã7æ¥)ãå šçåæéã145æ¥(å8æ¥)ãšãããããææã«é·ããªããŸãã(p<0.001)ã
骚ç€ã®éªšèè «ã¯å šäœãšããŠäºåŸãå³ãããã®ã®ãæ²»çã«ãã£ãŠçåæéãå»¶ã³ãå¯èœæ§ãããããšã瀺ãããããŸã§ã§æå€§èŠæš¡ã®å ±åãšãããŸããèè ãã¯ãäžé ããšã«åããããæè¡ã»æŸå°ç·ã»æããå€ãçµã¿åãããæ²»çãäžéšã®ç¬ã«åœ¹ç«ã€å¯èœæ§ããããšããŠããŸããäžæ¹ãåŸãåãç ç©¶ã§ãæ²»çãåããç¬ãšåããªãã£ãç¬ã¯ããšããšã®ç¶æ ãç°ãªãå¯èœæ§ããããæ²»çæ³ããšã®å¹æãæ¯ã¹ããããã®ã§ã¯ãããŸãããå€å€éè§£æã§ã¯ãäœéãéãããšã蚺æãŸã§ã®æéãçãããšãè¯ãçµéãšé¢é£ããåŸåãã¿ãããŸããã倧åç¬ã®åŸãè¶³ã®ã³ã£ãããè °ãè§Šããšçããããããç¶ãå Žåã¯é¢ç¯çãšæ±ºãã€ãããæ©ãã«å蚺ããŠã¬ã³ãã²ã³ãªã©ã®æ€æ»ã«ã€ããŠç£å»åž«ãšçžè«ããŸãããã
ð https://pubmed.ncbi.nlm.nih.gov/42630097/
ð¥ å»çã»çŸç ã»äºé²
3. ð¥ å»çã»çŸç ã»äºé²
ç¬ã®å¯è ã®è€è²çްèè «ãè¡æ¶²ã§èŠåããæããããããœã¹ã¿ãã³ãââã«ãã³ãŒã«ã¢ãã³ç£çè «ç12é ã®äžå€®å€0.82nmol/Lã¯å¯è ç®è³ªè «ç12é ã®0.50nmol/Lããé«å€ããã ãåºæºç¯å²ãè¶ ããã®ã¯12é äž5é (ã¹ãŠã§ãŒãã³èŸ²æ¥ç§åŠå€§åŠã»æ¥æ¬å€§åŠãBMC Vet Res)
ð 2026.10.16
ã¹ãŠã§ãŒãã³èŸ²æ¥ç§åŠå€§åŠ(SLU)ã®Josefine Prabertæ°ãOdd Viking Höglundæ°ããšãæ¥æ¬å€§åŠåç©ç é¢ã®çäŸãçšããæ¥æ¬ã®å ±åç ç©¶è (Ishigaki Kæ°ãAsano Kæ°)ãå«ãç ç©¶ããŒã ã¯ãç¬ã®ã«ãã³ãŒã«ã¢ãã³(ã¢ãã¬ããªã³ãªã©)ãç£çããè «çãè¡æ¶²æ€æ»ã§èŠåããææšã調ã¹ãç ç©¶ããBMC Veterinary Researchèªã«10æ16æ¥ã«çºè¡šããŸãããæ¥æ¬å€§åŠåç©ç é¢ã§èšºçãåããç¬ã察象ã«ãå¯è ã®è€è²çްèè «11é ãšå¯è å€ã®åç¥çµç¯è «1é ã®èš12é ãšãå¯è ç®è³ªè «çã®ç¬12é ã®æè¡åã®è¡æŒ¿ãæ¯ã¹ãŸãããæž¬å®ããã®ã¯ãç¥çµå åæ³çŽ°èãã€ããããã±ã質ãã¯ãã¢ã°ã©ãã³Aãã®æçã§ããããœã¹ã¿ãã³ãšã«ãã¹ã¿ãã³ã§ããããœã¹ã¿ãã³ã®äžå€®å€ã¯ã«ãã³ãŒã«ã¢ãã³ç£çè «çã®çŸ€ã§0.82nmol/Lãå¯è ç®è³ªè «çã®çŸ€ã§0.50nmol/Lãšãåè ãææã«é«ãå€ã§ãã(P=0.0374)ãã«ãã³ãŒã«ã¢ãã³ç£çè «çã®12é äž5é ã¯å¥åº·ãªç¬ã®åºæºç¯å²(0.11ã1.30nmol/L)ãäžåããŸããããå¯è ç®è³ªè «çã®ç¬ã§ã¯äžé ãäžåããŸããã§ãããã«ãã¹ã¿ãã³ã«ã¯çŸ€éã®å·®ã¯ãªããæè¡ååŸã®æ¡è¡ãã§ãã6é ã§ã¯è¡åŸã«ããœã¹ã¿ãã³ãäžããåŸåãã¿ããããã®ã®ãææå·®ã¯ãããŸããã§ããã
è€è²çްèè «ã¯è¡å§ã®æ¥å€ãªã©ãèµ·ãããæè¡ã®å±éºæ§ãé«ãè «çã§ãå¯è ç®è³ªè «çãšã®åºå¥ã¯æ²»çæ¹éãæè¡åã®æºåãå·Šå³ããŸããä»åã®çµæã¯ãããœã¹ã¿ãã³ãäžéšã®ç¬ã§èšºæãçµé芳å¯ã®è£å©ã«ãªãããããšã瀺ããæŠå¿µå®èšŒã®æ®µéã§ãèè ãã¯ãã¹ãŠã®è€è²çްèè «ãæŸãäžããåç¬ã®ã¹ã¯ãªãŒãã³ã°æ€æ»ã«ã¯é©ããªããšããŠããŸããå矀12é ãšå°æ°ã§ãåºæºç¯å²ãéå»ã®ããŒã¿ã«åºã¥ãããšãå°¿äžã«ãã³ãŒã«ã¢ãã³ãªã©ãšã®æ¯èŒããªãããšãéçã§ããå¥åº·èšºæã®è¶ 鳿³¢æ€æ»ã§å¯è ã®è «ããææãããå Žåã¯ãè¡å§æž¬å®ããã«ã¢ã³æ€æ»ãCTãªã©å¿ èŠãªæ€æ»ã®é²ãæ¹ãç£å»åž«ãšããçžè«ããŸãããã
ð https://link.springer.com/article/10.1186/s12917-026-05996-6
ð¥ å»çã»çŸç ã»äºé²
4. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®å£ã®äžã®ãæ£çŽ°èæ§ãšãã¡ã«äžç®è «ãã«äººã®ä¹³ããæ²»çè¬ãã©ããããå¹ãå¯èœæ§ââ1现èè§£æã§è «çç¹æã®ç¥çµçްèã«äŒŒã现èãšERBB4éºäŒåãçºèŠãæªæ§ã®æå¹³äžç®çãšã®èª€èšºã¯çŽ3ä»¶ã«1ä»¶(ã³ãŒãã«å€§åŠãMol Ther Oncology)
ð 2026.08.18
ç±³ã³ãŒãã«å€§åŠç£å»åŠéšã®å士課çšåŠçAndreas Stephanouæ°(çé èè )ãPraveen Sethupathyæ°ãSantiago Peraltaæ°(責任èè )ãã®ç ç©¶ããŒã ã¯ãç¬ã®å£è è «çãæ£çŽ°èæ§ãšãã¡ã«äžç®è «(CAA)ãã«é¢ããç ç©¶ãMolecular Therapy Oncologyèªã«7æ21æ¥ã«çºè¡šãã倧åŠã8æ18æ¥ã«ç޹ä»ããŸãããCAAã¯è»¢ç§»ããªãè¯æ§ã®è «çã§ãããåšå²ã®é¡ã®éªšãªã©ã«æ·±ãå ¥ãèŸŒãæ§è³ªãããã転移ããæªæ§ã®å£è æå¹³äžç®ç(COSCC)ãšèŠãç®ã䌌ãŠãããããçŽ3ä»¶ã«1ä»¶ã®å²åã§èª€ã£ãŠèšºæããããšãããŸããç ç©¶ããŒã ã¯ãPeraltaæ°ãæäŸããçæ€çµç¹ãã现èãäžã€ãã€èª¿ã¹ããã·ã³ã°ã«ã»ã«RNAã·ãŒã±ã³ã¹ãã§è§£æããŸããããã®çµæãCAAã«ã ãååšãããç¥çµçްèã«äŒŒãæ§è³ªããã€ãŸããªçްèã®éå£ãèŠã€ããããããã®çްèã¯ERBB4ãšããéºäŒåãçºçŸããŠããŸãããERBB4ã¯äººã®äžéšã®ä¹³ãããªã©ã§ç ç©¶ãããŠããéºäŒå矀ã«å±ããŸããããã«ãçããCAAã®è «ççµç¹ã«æ°åçš®é¡ã®è¬ã詊ãããšãããERBB4ãé»å®³ãã人ã®ä¹³ããæ²»çè¬ãã©ããã(ç±³FDAæ¿èªè¬)ãè «çã®å¢æ®ã广çã«æããŸããã
ãã®çºèŠã¯ãCAAãšæå¹³äžç®çããã確å®ã«èŠåããæãããã«ãªããšåæã«ãæ¢åè¬ã転çšããæ°ããæ²»çã®å¯èœæ§ã瀺ããã®ã§ããç ç©¶ããŒã ã¯ä»åŸãç¬ã®æ£è ã§ãã©ãããã®èšåºè©Šéšãè¡ãããšãããããŠããŸãããã ãä»åã®çµæã¯æ¡åããè «ççµç¹ã䜿ã£ãå®éšå®€ã§ã®ææã§ãå®éã®ç¬ã§ã®å¹æãå¯äœçšã¯ãŸã 確ãããããŠããŸããããŸããå ±éã§ã¯è§£æããæ€äœæ°ãªã©ã®è©³ããæ°å€ã¯ç€ºãããŠããŸãããæ¯ããã®ãµããã¿ãããããæ¯ã®ããã€ãããã ããå£ã®åºè¡ã«æ°ã¥ãããæ©ãã«å蚺ããçµç¹æ€æ»ã§è «çã®çš®é¡ã確ãããããã§æ²»çæ¹éãç£å»åž«ãšçžè«ããŸãããã
ð https://news.cornell.edu/stories/2026/08/existing-drug-could-treat-invasive-canine-oral-tumors
𧬠ç ç©¶ã»ç§åŠ
5. 𧬠ç ç©¶ã»ç§åŠ
ç¬ã®é«èè «190äŸã人ãšç¬ã®ç çå»ãå ±åã§åè©äŸ¡ã人ã®WHOã°ã¬ãŒãåé¡ã§ã¯ç¬ã®äºåŸãäºæž¬ã§ããââ57%ãã°ã¬ãŒã2ãæè¡ã®ã¿ã®çåæéäžå€®å€ã¯437æ¥ã壿»ã¯äºåŸã®ç®å®ã«ãªãå¯èœæ§(ç±³åœç«ããç ç©¶æã®æ¯èŒè³è «çã³ã³ãœãŒã·ã¢ã ãVeterinary Oncology)
ð 2026.07.28
é«èè «ã¯ç¬ã§æãå€ãè³è «çã®äžã€ã§ããç±³åœç«ããç ç©¶æ(NCI)ã®æ¯èŒè³è «çã³ã³ãœãŒã·ã¢ã (CBTC)ã®é«èè «ç çå§å¡äŒã¯ãç£å»ç çå»ãšäººã®ç¥çµç çå»ãå ±åã§ãç±³åœã®10ã®ç£å»å€§åŠã«ä¿ç®¡ãããŠããæ²»çåã®ç¬ã®é«èè «190äŸã人ã®2016幎çWHOåé¡ã»ã°ã¬ãŒãåºæºã§èŠçŽããç ç©¶ããVeterinary Oncologyèªã«7æ28æ¥ã«ãªã³ã©ã€ã³çºè¡šããŸãã(çé èè Molly E. Churchæ°ã責任èè Amy LeBlancæ°ã17人)ãçµç¹åã§ã¯ãé«èç®æ§ãã190äŸäž140äŸ(çŽ74%)ãšæå€ã§ãã°ã¬ãŒãã¯ã°ã¬ãŒã1ã79äŸãã°ã¬ãŒã2ã109äŸ(57%)ãã°ã¬ãŒã3ã2äŸã§ãããè©äŸ¡ã§ããçäŸã®çŽ60%ã§ãè «çãåšå²ã®è³ãèé«ãªã©ã®ç¥çµçµç¹ã«å ¥ã蟌ãã§ããŸãããããããã°ã¬ãŒã1ãš2ã®éã§çåã«ææãªå·®ã¯ãªãã1幎ã»2幎ã»3幎ã§ã®æ»äº¡ã®çžå¯Ÿãªã¹ã¯ã¯0.75ã0.93ã1.02ãšããããææã§ã¯ãããŸããã§ãããäžæ¹ãçµéã詳ãã远ããçäŸã§ã¯ã壿»(çµç¹ã®äžéšãæ»ãã§ããæèŠ)ã®ããçäŸã¯ãã¹ãŠé²è¡ãã壿»ã®ãªãçäŸã§ã¯57%ã§ãããæè¡ã®ã¿ã®ç¬ã®çåæéã®äžå€®å€ã¯437æ¥ã§ãæè¡ã«è¿œå ã®æ²»çãçµã¿åãããç¬ã§ã¯28ã55ã«æã®çåãã¿ãããŸããã
ç¬ãšäººã®é«èè «ã¯é¡åŸ®é¡ã§èŠããšéåžžã«äŒŒãŠããäžæ¹ã人ã®ã°ã¬ãŒãåé¡ããã®ãŸãŸç¬ã«åœãŠã¯ããŠãçµéã¯äºæž¬ã§ããªãããšãããããèè ãã¯ç¬å°çšã®ã°ã¬ãŒãåé¡ãå¿ èŠã ãšããŠããŸããç çå»ã©ããã®å€å®ã®äžèŽåºŠã¯æãé«ãé ç®ã§ãäžçšåºŠ(ICC 0.44)ã§ã现èåè£ã®æ°ãæ¹ã¯ç¹ã«ã°ãã€ãã倧ãããè©äŸ¡æ¹æ³ã®æšæºåã課é¡ã§ããéå»ã®ä¿åæšæ¬ã䜿ã£ãç ç©¶ã§ãæ²»çå 容ãçäŸããšã«ç°ãªãç¹ã«ã泚æãå¿ èŠã§ããé«éœ¢ã®ç¬ã§çºäœãæ°ãã«å§ãŸã£ããããµãã€ããæåãæ§æ Œã®å€åãã¿ããããããå Žåã¯è³ã®ç æ°ã®å¯èœæ§ããããããæ©ãã«å蚺ããMRIãªã©ã®æ€æ»ãæ²»çã«ã€ããŠç£å»åž«ãšçžè«ããŸãããã
ð https://link.springer.com/article/10.1186/s44356-026-00068-1
𧬠ç ç©¶ã»ç§åŠ
6. 𧬠ç ç©¶ã»ç§åŠ
ç¬ãšäººã®éªšèè «çŽ°èã®å¢æ®ãéçºäžã®è¬ãTelomir-Znããæå¶ââç¬ã®çŽ°èæ ª2çš®ãšäººã®çŽ°èæ ª1çš®ã§ãåçšåºŠã®äœãæ¿åºŠã§çšéã«å¿ãã广ãç¬ã§ã®è©Šéšã¯ãªãã€ãªå·ç«å€§åŠãšåè°äž(Telomir Pharmaceuticals)
ð 2026.09.14
ç±³ãããªãå·ãã€ã¢ãã®Telomir Pharmaceuticalsã¯9æ14æ¥ããªãã€ãªå·ç«å€§åŠç£å»åŠéšã®Shay Brachaåææ(ç£å»è «çå ç§å°éå»)ãçããç ç©¶ã§ãå瀟ãéçºäžã®ååç©ãTelomir-Znãã人ãšç¬ã®éªšèè «çŽ°èã®å¢æ®ãæãããšçºè¡šããŸãã(dvm360ã9æ22æ¥ã«å ±é)ãå®éšã¯å¹é€çްèã䜿ã£ããã®ã§ã人ã®éªšèè «çŽ°èæ ªHOSãšãç¬ã®éªšèè «çŽ°èæ ªD17ãšAbramsã®èš3çš®é¡ã§èª¿ã¹ãŸããããã®çµæã3çš®é¡ãã¹ãŠã§åçšåºŠã®äœãæ¿åºŠã§å¢æ®ãæããããæ¿åºŠãé«ãã»ã©å¹æã匷ãŸãçšéäŸåçãªæè «çäœçšã確èªããããšãããŸããå瀟ã«ãããšãTelomir-Znã¯çްèå ã®éãé ã®èª¿ç¯ã«åããããéã«äŸåããŠéºäŒåã®åãã調ç¯ããé µçŽ (ãã¹ãã³è±ã¡ãã«åé µçŽ )ãé»å®³ãããšãããŠããŸããå瀟ã¯çŸåšã人ã®ããªãã«ãã¬ãã£ãä¹³ããã察象ã«FDAããèšåºè©Šéš(第1/2çž)ã®éå§ãèªããããŠãããç¬ã®éªšèè «ã«ã€ããŠã¯ãèªç¶ã«çºçããç¬ã§ã®å¹æã調ã¹ã詊éšã®å®æœããªãã€ãªå·ç«å€§åŠãšåè°äžã§ããBrachaæ°ã¯ã倧åç¬ã®éªšèè «ã¯äŸç¶ãšããŠæ·±å»ã§ãæ²»çã®éžæè¢ã¯éãããäºåŸãæªãããšã³ã¡ã³ãããŠããŸãã
骚èè «ã¯å€§åç¬ã®åçºæ§éªšè «çã®80ã90%ãå ãããšããã人ã®å°å ã»è¥å¹Žè ã®éªšèè «ãšããã䌌ãŠãããããæ°ããè¬ã®éçºã¯ç¬ãšäººã®äž¡æ¹ã«åœ¹ç«ã€å¯èœæ§ããããŸãããã ãä»åã¯äŒæ¥ã®çºè¡šã«ãã现èå®éšã®æ®µéã§ãå ·äœçãªè¬ã®æ¿åºŠãæå¶ã®çšåºŠã¯å ¬è¡šãããŠããããæ»èªãçµãè«æãšããŠçºè¡šããããã©ããã瀺ãããŠããŸãããç¬ã§ã®è©Šéšã¯å®æœãææã決ãŸã£ãŠããŸããã倧åç¬ãè¶³ãçãããè «ããŠãããã³ã£ããæ²»ããªããšãã£ãæ§åãããã°æ©ãã«å蚺ããçŸåšã®æšæºæ²»çã§ããæèãæããå€ãçã¿ã®ç®¡çã«ã€ããŠç£å»åž«ãšçžè«ããŸãããã
𧬠ç ç©¶ã»ç§åŠ
7. ð¥ å»çã»çŸç ã»äºé²
ãæ¥æ¬ãç«ã®èã®æå¹³äžç®çã«ã黿°ååŠçæ³ããçã¿ã®ã¹ã³ã¢ã17ãã1ã«äžããèªåã§é£ã¹ãããããã«ââ14æ³ã®ãã«ã·ã£ç«ãäœéã¯1.7kgãã2.6kgã«å埩ãè äžå šã§äº¡ããªããŸã§120æ¥(麻åžå€§åŠã»ããFront Vet Sci)
ð 2026.07.20
ç¥å¥å·ç倧ååžã®ç§ååç©ç é¢ãšéº»åžå€§åŠã®ç§åèª æ°ãããã³éº»åžå€§åŠå°åç©å ç§åŠç 究宀ã®ä¹ æ«æ£æŽæ°ã¯ãèã«ã§ããæå¹³äžç®çã®ç«ã«é»æ°ååŠçæ³ãè¡ã£ãçäŸå ±åããFrontiers in Veterinary Scienceèªã«7æ20æ¥ã«çºè¡šããŸããã黿°ååŠçæ³ã¯ãæããå€ãæäžããåŸã«è «çãžçã黿°ãã«ã¹ããããŠçްèèã«äžæçã«ç©Žããããè¬ãè «ç现èã«åã蟌ãŸããããããæ²»çã§ãã察象ã¯14æ³ã®é¿åŠæžã¿ã®éã®ãã«ã·ã£ç«ã§ãå蚺æã®äœéã¯1.7kgãããã£ã³ã³ãã£ã·ã§ã³ã¹ã³ã¢ã¯9段éäž1ãšãããŠãããã¹ããŒãž3ã®æ ¢æ§è èç ããããŸãããæããå€ãã¬ãªãã€ã·ã³(20mg/m²)ãéèå ã«æäžãã8ååŸã«8æ¬ã®éç¶é»æ¥µã§é»æ°ãã«ã¹ããããæ²»çãã3æ¥ç®ã31æ¥ç®ã81æ¥ç®ã®èš3åè¡ããŸãããç«ã®çã¿ã®è©äŸ¡ã¹ã³ã¢(UFEPS)ã¯æ²»çåã®17ããã10æ¥ç®ã«7ã31æ¥ç®ã«2ã59æ¥ç®ã«1ãŸã§äžãããŸãããç«ã¯åã³èªåã§é£ã¹ãã飲ãã ãã§ããããã«ãªããäœéã¯59æ¥ç®ã«2.6kgãŸã§å埩ããŸãããç«ã¯æ²»çéå§ãã120æ¥åŸã«ãè «çã®é²è¡ãšã¯é¢ä¿ã®ãªãå°¿æ¯ç(è äžå š)ã§äº¡ããªããŸããã
èã®ããã¯é£ã¹ãã»é£²ãã»æ¯ã¥ããããšãã£ãç«ã®ç掻ã«çŽçµãããããèè ãã¯ãè «çãå°ããããããšã ãã§ãªããèã®æ©èœãä¿ã€ããšãæ²»çã®æåã®åºæºã«å«ããã¹ãã ãšããŠããŸããäžæ¹ãæ»åŸã®ç çæ€æ»ã§ã¯ãçåã«ã¯ç°åžžãèŠã€ãããªãã£ãèã®ä»ãæ ¹ãææ¡ãåé èã«ãŸã§ãããåºãã£ãŠãããèŠããªããšããã§é²è¡ããŠããå¯èœæ§ã瀺ãããŸããã1é ã®ã¿ã®å ±åã§ãCTãªã©ã®ç»åæ€æ»ã«ããç æã®è©äŸ¡ãã§ããŠããªãããšãé®çè¬ãªã©ã®æ¯æçæ³ã®åœ±é¿ãåãåããããªãããšãéçã§ã广ã®ç¢ºèªã«ã¯ããå€ãã®çäŸã§ã®ç ç©¶ãå¿ èŠã§ããç«ããã ããåãããé£ã¹ã«ãããã«ãããå£èã匷ããªããå£ããåºè¡ãããšãã£ãå€åãããã°æ©ãã«å蚺ããå£ã®äžããã蚺ãŠããã£ãããã§æ²»çã®éžæè¢ãç£å»åž«ãšçžè«ããŸãããã
ð https://www.frontiersin.org/journals/veterinary-science/articles/10.3389/fvets.2026.1850098/full
ð¥ å»çã»çŸç ã»äºé²
ðïž ç¬ç«è «çãã¥ãŒã¹ | all-i-need-are-dogs.blog

ã³ã¡ã³ããã©ãã